1. Home
  2. CERS

as 06-13-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Technology

EDP Services

Nasdaq

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Founded: 1991 Country:
United States
United States
Employees: 280 City: CONCORD
Market Cap: 332.8M IPO Year: 1997
Target Price: $3.25 AVG Volume (30 days): 1.4M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $1.21 - $3.08 Next Earning Date: 07-31-2024
Revenue: $191,716,000 Revenue Growth: 4.32%
Revenue Growth (this year): 3.72% Revenue Growth (next year): 13.56%

CERS Daily Stock ML Predictions

Stock Insider Trading Activity of Cerus Corporation (CERS)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Shan Hua CERS Director May 13 '24 Buy $1.99 2,500 $4,974.75 32,386 SEC Form 4
NACHTSHEIM JAMI K CERS Director May 10 '24 Buy $1.79 2,000 $3,578.20 108,362 SEC Form 4
Swisher Daniel N JR CERS Director May 9 '24 Buy $1.88 2,500 $4,688.75 107,045 SEC Form 4
Witney Frank CERS Director May 9 '24 Buy $1.89 20,000 $37,800.00 180,059 SEC Form 4
Jayaraman Vivek K CERS Chief Operating Officer Mar 12 '24 Sell $2.06 26,247 $53,990.08 905,447 SEC Form 4
Jayaraman Vivek K CERS Chief Operating Officer Mar 12 '24 Sell $1.97 26,794 $52,902.07 878,653 SEC Form 4
Benjamin Richard J CERS Chief Medical Officer Mar 12 '24 Sell $2.06 17,377 $35,744.49 477,350 SEC Form 4
Benjamin Richard J CERS Chief Medical Officer Mar 12 '24 Sell $1.97 17,738 $35,021.91 459,612 SEC Form 4
Green Kevin Dennis CERS Chief Financial Officer Mar 12 '24 Sell $2.02 21,058 $42,438.19 640,247 SEC Form 4
Green Kevin Dennis CERS Chief Financial Officer Mar 12 '24 Sell $1.97 21,497 $42,443.68 618,750 SEC Form 4
Moore Carol CERS SVP Reg. & Quality Mar 12 '24 Sell $2.06 10,203 $20,987.57 501,039 SEC Form 4
Moore Carol CERS SVP Reg. & Quality Mar 12 '24 Sell $1.97 10,416 $20,565.35 490,623 SEC Form 4
Greenman William Mariner CERS President and CEO Mar 12 '24 Sell $2.06 62,315 $128,181.96 3,244,892 SEC Form 4
Greenman William Mariner CERS President and CEO Mar 12 '24 Sell $2.02 63,611 $128,195.25 3,181,281 SEC Form 4
CORASH LAURENCE M CERS Chief Scientific Officer Mar 12 '24 Sell $2.06 14,067 $28,935.82 2,354,100 SEC Form 4
CORASH LAURENCE M CERS Chief Scientific Officer Mar 12 '24 Sell $1.97 14,360 $28,352.38 2,339,740 SEC Form 4
Benjamin Richard J CERS Chief Medical Officer Mar 8 '24 Sell $2.40 29,378 $70,457.26 478,061 SEC Form 4
BJERKHOLT ERIC CERS Director Dec 13 '23 Buy $1.62 10,000 $16,200.00 142,133 SEC Form 4

Share on Social Networks: